Publisher
Springer Berlin Heidelberg
Reference112 articles.
1. AGIS Investigators (2000): The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130: 429–440
2. American Academy of Ophthalmology, Preferred Practice Pattern Guidelines (2015): Age Related Macular degeneration. San Francisco, CA, 2015. Age-Related Macular Degeneration PPP - Updated 2015 ( http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015 )
3. American Academy of Ophthalmology Retina/Vitreous Panel, Preferred Practice Pattern Guidelines (2017): Diabetic Retinopathy. San Francisco, CA, 2017. Diabetic Retinopathy PPP - Updated 2017 ( http://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-pppupdated-2017 )
4. Aroney C, Fraser-Bell S, Lamoureux EL, Gillies MC, Lim LL, Fenwick EK (2016): Vision-related quality of life outcomesin the BEVORDEX study: a clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci. 57: 5541–5546
5. Bahrami B, Hong T, Zhu M, Schlub TE, Chang A (2017): Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 255: 1133–1140